TABLE 1. THE BENEFITS OF QUITTING SMOKING START RIGHT AWAY

hours:
• Chance of heart attack drops
• Ability to smell and taste improves
2-3 weeks:
• Circulation improves • Walking becomes easier • Lung function improves 1 month:
• Cough, sinus congestion, fatigue, and shortness of breath decrease • Cilia re-grow, reducing infection risk 1 year:
• Excess risk of coronary heart disease is half that of a smoker 5 years:
• Risk of cancer of the mouth, throat, and esophagus drops by about half • Risk of stroke and coronary heart disease is reduced to that of non-smokers (about 5 to 15 years after quitting)
years:
• The risk of lung cancer drops by about half • Lung cancer death rate approaches that of non-smokers 
Brief Counseling
Nicotine addiction is a chronic disease, and relapse after initially successful treatment is not uncommon. Persistent efforts are required, but proven techniques for brief counseling are quick and easily integrated into a busy practice (see infold).
Ask every patient about smoking status at every office visit. Most will give a direct answer, which can be noted with a line or sticker on the front sheet of the medical record:
Some patients may at first be uncomfortable telling their doctors they smoke -persons with known heart, vascular, or lung disease and pregnant women, for example. Open-ended questions often work better with these patients.
Practioners should ask former and current smokers how much and how long they've smoked. All patients for whom tobacco poses a special risk should understand that risk. In the case of pregnancy, the risk to the fetus posed by tobacco is high, and firm counseling is indicated.
Is the Patient Addicted?
Counseling and (unless containdicated) pharmacotherapy should always be offered to addicted smokers. Strongly addicted patients have a high risk of relapse and may need prolonged treatment.
Does the Patient Want to Quit?
Combine this question with a clear statement of the importance of quitting and an offer to help:
"Quitting smoking is the most important thing you can do for your health. We can help you quit."
Physician advice must be clear, strong, and personal. If a patient is at risk for a particular medical problem, tailored information strengthens the message ( Table 2) . 
Special Medical Reasons
• Coronary artery disease and hypertension. Risk of a first heart attack decreases as soon as the patient quits, drops by 50% the first year, and continues to fall.
• Previous myocardial infarction. Risk of another heart attack will be reduced by 50%.
• Peripheral vascular disease. 90% of persons with peripheral vascular disease are smokers. All will do better if they quit, and some with early disease will be completely relieved of symptoms.
• Diabetes. Smoking dramatically increases the risk of vascular complications. Quitting immediately lowers this risk.
• Chronic obstructive pulmonary disease. The lungs of people with alpha-1 anti-trypsin deficiency are especially sensitive to tobacco smoke; most who start smoking at a young age will develop severe COPD. Death rates from COPD are 10 times higher among persons who smoke a pack a day than among non-smokers. Modest improvement in lung function is expected when a symptomatic patient stops smoking. The most important benefit, however, is immediate reduction in the rate of disease progression.
• Combined hormonal contraception. Smokers who use combined hormonal contaception have a higher risk of heart attack, stroke, and thromboembolic disease, especially those 35 and older. After quitting, the risk falls immediately.
• Pregnancy. Women who smoke are more likely to have miscarriages and stillbirths. Their babies are on average 500 grams lighter, and more likely to die or be developmentally delayed. The babies of smoking mothers are more likely to die of sudden infant death syndrome.
• Macular degeneration and cataract. Blindness from these causes is twice as common among smokers.
• Surgery. Patients who stop smoking before surgery heal better and cut their risk of infection and pulmonary and vascular complications.
TABLE 2. WHY QUIT SMOKING?
• Reduce your risk of:
• Heart attack, stroke, and coronary heart disease.
• Cancers of the mouth, larynx, esophagus, lung, blood, stomach, pancreas, bladder, kidney, urethra, cervix, colon.
• Emphysema, bronchitis, asthma, and pneumonia.
• Blindness, aortic aneurysm, and infertility (women).
• Reduce the chance that:
• Your children will develop or suffer from worsened asthma, middle-ear infections, and bronchitis.
• Your family will develop cancer, heart disease, and other illnesses caused by second-hand smoke.
• Your children will smoke.
• More money in your pocket! With such strong evidence, it makes sense to offer counseling, quit tips, and (unless contraindicated) drug treatment to all smokers (Tables 3, 4) . Clinical judgment will be needed for the use of drug therapy for adolescents and patients with conditions that complicate treatment, such as pregnancy, substance abuse, and mental illness ( 
General Reasons
Follow-Up Counseling
Subsequent counseling can be individual, group, by telephone, or on the Web.
Intensive individual or group counseling greatly increases the odds of success. Counseling should highlight the health and financial costs of smoking versus the benefits of stopping ( Table 2 ). Counseling should also provide practical tips (Table 3) . Single-session counseling is less effective than a series of sessions. There is a strong doseresponse relationship: effective counseling consists of 4 or more sessions, each at least 10 minutes long. Counseling is even more effective if several types of clinicians (e.g., doctors, nurses, and counselors) reinforce smokingcessation messages.
• All patients should be given quit tips, educational materials, and phone numbers and Web sites for support. 
Consider nicotine replacement products and other medication.
• Nicotine replacement therapy and medication such as bupropion ease irritability, depressed mood, difficulty concentrating, insomnia, and smoking urges.
• Even without drugs, withdrawal symptoms usually peak the first week, last 2 to 4 weeks, and then subside.
Identify smoking triggers.
• Alcohol, other smokers, caffeine, and stress (including time pressure) are common triggers.
• Establish a smoke-free home.
Identify coping strategies.
• Keep busy.
• Stay in non-smoking areas.
• Drink lots of water.
• Exercise to relieve stress, elevate mood, and improve health. Try a daily, 30-minute, brisk walk.
Set a quit date and prepare for it.
• Discard cigarettes, lighters, and ashtrays at home and in the car.
• Choose a "normal" quit date (no vacations/holidays, major work deadlines, or big life events such as weddings, moving, etc.).
Get support.
• Get a "quitting buddy."
• For help, including free or low-cost counseling and other services, call 311. 
Objectives
At the conclusion of the course, the participants 1. The health risks of tobacco use and the health benefits of quitting smoking 2. The clinical assessment of nicotine addiction 3. Effective interventions for treating nicotine addi counseling and pharmacotherapy 4. Conditions that may complicate the treatment including weight gain, concurrent psychiatric 5. The relative advantages and disadvantages of th used to treat nicotine addiction
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Treating Nicotine Addiction
• Offer quit tips ( Table 3 ).
• Encourage counseling and (unless contraindicated) pharmacotherapy. The most effective counseling uses multiple clinician types and 4 or more sessions, each at least 10 minutes long. • Follow up (by telephone or in person) before, near, and after the quit date.
Commend and encourage tobacco-free living.
Does the patient want to quit?
Ask every patient about tobacco use at every office visit.
• • Avoid argument.
• Make sure your patient fully understands the risks of smoking to self and family.
• Ask about prior quit attempts and discuss barriers to quitting, including:
• Nicotine addiction.
• Substance abuse.
• Depression.
• Concern about weight gain.
• Lack of social support.
• Previous relapse (fear of failure).
• Explain how pharmacotherapy and counseling can make it easier to quit. 
Not Yet Not Yet
• Commend and encourage tobacco-free living.
• Discuss any problems that could lead to relapse (e.g., depression, weight gain, substance abuse, being around smokers).
• Ask about prior quit attempts, and discuss barriers to quitting, including:
• Explain how pharmacotherapy and counseling can make it easier to quit.
• Ask your patient to think about a quit date.
• Arrange follow-up.
Never Used Never Used Former User Former User Current User Current User
Who should receive pharmacotherapy for smoking cessation?
• Everyone, except in special circumstances. Special consideration should be given before using pharmacotherapy for patients with medical contraindications, those smoking fewer than 10 cigarettes/day, pregnant/breastfeeding women, and adolescents.
Are pharmacotherapeutic treatments appropriate for lighter smokers (fewer than 10 cigarettes/day)?
• If pharmacotherapy is used with lighter smokers, clinicians should consider reducing the dose of first-line nicotine replacement therapy (NRT) and using ad libitum formulations, such as gum or lozenges. No adjustments are necessary when using sustained-release bupropion (bupropion SR) only.
Which pharmacotherapies should be considered for patients worried about weight gain?
• Bupropion SR and nicotine replacement therapies, in particular nicotine gum, have been shown to delay, but not prevent, weight gain.
Are there pharmacotherapies that warrant particular consideration in patients with a history of depression?
• Bupropion SR and nortriptyline appear to be effective in this population ( Table 7) .
Can NRT be used in patients with a history of cardiovascular disease?
• Yes. In particular, the nicotine patch is safe and has been shown not to cause adverse cardiovascular effects.
Can pharmacotherapies for smoking cessation be used long term?
• Yes. Most patients achieve maximum benefit with 6 to 8 weeks of treatment. However, for some patients, long-term treatment may be helpful (e.g., smokers with persistent withdrawal symptoms or those who desire long-term therapy). A minority of individuals who successfully quit smoking use ad libitum NRT medications (gum, nasal spray, or inhaler) long term. The long-term use of these medications does not present a known health risk. Additionally, the Food and Drug Administration has approved bupropion SR for long-term maintenance.
Can pharmacotherapies be combined?
• Yes. There is evidence that combining the nicotine patch with either nicotine gum or nicotine nasal spray has an additive effect, raising long-term quit rates above those produced by a single form of NRT. • Concurrent psychiatric or substance abuse problems. The prevalence of smoking is high among persons with mental illness and substance abuse. It is usually more difficult for these persons to quit, and relapse is more common. Carefully adjusted nicotine replacement therapy is extremely useful in this population.
BRIEF COUNSELING FOR TOBACCO CESSATION
TREATING NICOTINE ADDICTION
When sustained-release bupropion is used with other psychotropic drugs, patients should be cared for by a psychiatrist. Bupropion SR should not be used with monoamine oxidase inhibitors or by patients with an eating disorder. It must be used with caution in patients taking levodopa and drugs that lower the seizure threshold. Patients with a history of depression should be followed closely for depressive symptoms. Patients taking certain psychotropic medications may need dose adjustments when they quit smoking.
• Pregnancy. The risk to the fetus posed by smoking is clear. Most pregnant women stop smoking on their own. Those who do not are usually addicted and need intensive counseling. Bupropion SR can be used during pregnancy if non-drug interventions fail, but should be used with caution because it lowers the threshold for seizures. The risk to the fetus from nicotine replacement or bupropion SR should be balanced against the greater risk of maternal smoking.
• Adolescence.
Helping adolescents quit can be difficult. They usually smoke less than adults, but may be addicted. The safety and efficacy of bupropion SR and NRT in adolescents, however, has not been established; neither is approved by the FDA for use in people 17 and younger.
• Relapse. Nicotine addiction is a chronic disease. Many patients relapse, even several times, before they quit permanently. The physician has an obligation to ensure follow up, with an opportunity for re-treatment as needed. Most smokers who stop for 6 months or more never become regular smokers again. To ensure continued monitoring, incorporate smoking status into the vital signs at every follow-up visit.
